slides · global inventory
Consultants Gambit
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 39,432
Current window 33,061-33,090
Pages 1,315
Rows per page 30
Arc
33,061-33,090 of 39,432
01
Features a photo of a child named Albie living with LAL-D.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Situation & Context1 hit
02
AstraZeneca | Investor Day Presentation Deck | 49 slidesAstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Situation & Context1 hit
03
AstraZeneca | Investor Day Presentation Deck | 49 slidesAstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Situation & Context1 hit
04
AstraZeneca | Investor Day Presentation Deck | 49 slidesAstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Situation & Context1 hit
05
AstraZeneca | Investor Day Presentation Deck | 49 slidesAstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
06
The slide uses iconography to represent key statistics about rare diseases.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
07
AstraZeneca | Investor Day Presentation Deck | 49 slidesAstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
08
The slide uses a visual mapping of products to indications.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
09
The slide uses a horizontal bar chart format to represent clinical trial progress.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
10
The slide uses a human-centric image to transition into a business section about medical leadership.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
11
The slide uses a matrix-like layout to map drug candidates against biological targets and development status.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
12
The slide uses a biological process flow to explain the therapeutic rationale for C5 inhibition.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
13
The slide uses a timeline-like arrow to represent innovation and expansion into new indications.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
14
The slide uses a waterfall-style comparison for pricing and a 2x2 grid for indication-specific growth strategies.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
36
The table covers CY19A through CY24E, detailing revenue, EBITDA, EBIT, and various cash flow adjustments.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & ApproachLoop · Mece Breakdown1 hit
37
The slide presents a multi-year financial forecast (CY19A-CY25E) including revenue, EBITDA, EBIT, and various cash flow line items.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & ApproachLoop · Mece Breakdown1 hit
38
Morgan Stanley project slide, likely part of a valuation or M&A deck.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
39
Share counts as of 4/6/2022 Proxy, total share count does not tie to detailed Aggregate Value build as those share counts are as of the 2Q22 filing and detailing sharecount ownership is not provided.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
40
The slide presents a WACC calculation with low, base, and high scenarios, showing inputs like Market Risk Premium, Beta, and Risk-Free Rate.Morgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
41
Morgan Stanley | Investment Banking Pitch Book | 41 slidesMorgan Stanley | Investment Banking Pitch Book | 41 slides · Morgan Stanley
Consulting deck Investment bank Beat · Solution & Approach1 hit
01
Perella Weinberg Partners | Investment Banking Pitch Book | 10 slidesPerella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Situation & Context1 hit
02
The slide uses a table-like structure to organize qualitative insights about a financial model.Perella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Situation & Context1 hit
03
Perella Weinberg Partners | Investment Banking Pitch Book | 10 slidesPerella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Problem & Complication1 hit
04
Includes historical data from 2017-2021 and projections through 2032E, with CAGR analysis.Perella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Evidence & ProofLoop · Logic Chain1 hit
05
Includes PWP commentary highlighting growth in antimicrobials and margin dilution from diversification.Perella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Evidence & ProofLoop · Logic Chain1 hit
06
Includes a 'Preliminary' tag at the top.Perella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Evidence & ProofLoop · Logic Chain1 hit
07
Includes a 'Preliminary' watermark and source citation.Perella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Evidence & ProofLoop · Logic Chain1 hit
08
The table is split into two sections: one with annual projections (2022-2027) and one with static 'TAM at Maturity' figures for specific product categories.Perella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Evidence & ProofLoop · Logic Chain1 hit
09
The table tracks specific product rollouts across global regions (EMEA, APAC, LAR, NAR) for four business categories.Perella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
10
Perella Weinberg Partners | Investment Banking Pitch Book | 10 slidesPerella Weinberg Partners | Investment Banking Pitch Book | 10 slides · Perella Weinberg Partners
Consulting deck Investment bank Beat · Impact & Next Steps1 hit